Article Text

PDF
Enteropathy type T cell lymphoma with an unusually late relapse: a case report
  1. M Al Kaptan1,
  2. D Hui2,
  3. L Dabbagh3,
  4. T Reiman4,
  5. R Lai5
  1. 1Department of Laboratory Medicine and Pathology, University of Alberta and Cross Cancer Institute, Edmonton, Alberta, Canada
  2. 2Department of Medicine, University of Alberta and Cross Cancer Institute, Edmonton, Alberta, Canada
  3. 3Department of Laboratory Medicine and Pathology, University of Alberta and Cross Cancer Institute, Edmonton, Alberta, Canada
  4. 4Department of Medicine, University of Alberta and Cross Cancer Institute, Edmonton, Alberta, Canada
  5. 5Department of Laboratory Medicine and Pathology, University of Alberta and Cross Cancer Institute, Edmonton, Alberta, Canada
  1. Correspondence to:
    Dr R Lai
    Department of Laboratory Medicine and Pathology, University of Alberta and Cross Cancer Institute, 11560 University Avenue, Edmonton, Alberta, Canada T69 I22; raymondl{at}cancerboard.ab.ca

Statistics from Altmetric.com

Enteropathy type T cell lymphoma (ETTL) is a rare subtype of T cell lymphoma that is strongly associated with coeliac disease.1 The overall prognosis is poor. In one study, 15 of 19 (79%) patients relapsed within 60 months after the initial diagnosis (median, 6 months), and the overall survival rate at 5 years was 24%.2 We describe a case of ETTL with an unusually late relapse. The patient was a 50-year-old woman who developed an ulcerated gastric tumour in 1992, with no associated lymphadenopathy or hepatosplenomegaly. A partial gastrectomy was performed, and at the time of surgery, the tumour …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.